Tradestie Institutional Equity Comparison Engine
LCTX vs IMDX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
LCTX Overall Edge
LCTX Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Lineage Cell Therapeutics, Inc. (LCTX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, LCTX trades at 30.7x Forward P/E with -280.3% operating margin (-61.0% YoY revenue) versus IMDX at N/M Forward P/E and -1883.2% operating margin (+115.0% YoY). In options structure, LCTX sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro) against IMDX sits in BREAKDOWN (12th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
LCTX
LCTX 30.7x vs IMDX N/M Fwd P/E
Growth & Margin Winner
LCTX
Op Margin -280.3% vs -1883.2% ยท YoY -61.0% vs +115.0%
Momentum & Technical Winner
LCTX
1Y -53.7% vs -73.8% ยท 52W Pos 4% vs 3%
Options & Structure Winner
LCTX
BREAKDOWN (100th %ile IV) vs BREAKDOWN (12th %ile IV)
LCTX
NYSE American
Lineage Cell Therapeutics, Inc.
Biological Products, (No Disgnostic Substances)
$0.82
-2.21% 1D
Market Cap
$212.1M
1M Return
-13.82%
1Y Return
-53.67%
Forward P/E
30.7x
Unified AI Score
58.9 / 100
HOLD
Tech 65.0
Fund 54.0
Flow 65.0
Mom 45.0
IMDX
NASDAQ
Insight Molecular Diagnostics Inc. Common Stock
In Vitro & In Vivo Diagnostic Substances
$1.66
+4.4% 1D
Market Cap
$52.1M
1M Return
-45.03%
1Y Return
-73.78%
Forward P/E
N/M
Unified AI Score
45.5 / 100
HOLD
Tech 50.0
Fund 40.0
Flow 58.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
LCTX -53.67%
IMDX -73.78%
Spread: +20.11 pp (LCTX Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | LCTX Revenue | IMDX Revenue | LCTX Op. Margin | IMDX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | N/A | -837.9% | N/A | LCTX |
| FY2019 | $0M | N/A | -1106.0% | N/A | LCTX |
| FY2020 | $0M | $0M | -1448.4% | -2443.3% | LCTX |
| FY2021 | $0M | $0M | -1133.6% | -2444.3% | LCTX |
| FY2022 | $10M | $0M | -153.2% | -1878.6% | LCTX |
| FY2023 | $10M | $0M | -276.5% | -1672.4% | LCTX |
| FY2024 | $10M | $0M | -226.1% | -3245.1% | LCTX |
| FY2025 | $10M | $0M | -251.6% | -1260.8% | LCTX |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | LCTX | IMDX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $212.1M | $52.1M | Larger Scale | LCTX |
| Trailing P/E Ratio Valuation | 30.7x | N/M | Lower Multiple | LCTX |
| Forward P/E Ratio Valuation | 30.7x | N/M | Lower Multiple | LCTX |
| Revenue Growth (YoY) Growth | -61.0% | +115.0% | Higher Growth | IMDX |
| Operating Margin (TTM) Profitability | -280.3% | -1883.2% | Higher Margin | LCTX |
| Net Profit Margin Profitability | 16.2% | 0.0% | Higher Margin | LCTX |
| Return on Equity (ROE) Capital Efficiency | 4.3% | -23603.1% | Higher ROE | LCTX |
| 52-Week Range Position Momentum | 4% ($1โ$2) | 3% ($2โ$8) | Stronger Trend | LCTX |
| Beta / 30D Volatility Risk Regime | 1.36ฮฒ ยท 79% Vol | 2.91ฮฒ ยท 76% Vol | Lower Realized Risk | IMDX |
| Unified Institutional Score Composite Signal | 58.9 / 100 (HOLD) | 45.5 / 100 (HOLD) | Higher Composite | LCTX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full LCTX vs IMDX Buy Guide
LCTX
BREAKDOWN
6d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
IMDX
BREAKDOWN
117d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
12th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither LCTX nor IMDX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.